GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amrutanjan Health Care Ltd (NSE:AMRUTANJAN) » Definitions » EV-to-Revenue

Amrutanjan Health Care (NSE:AMRUTANJAN) EV-to-Revenue : 4.30 (As of Jun. 05, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Amrutanjan Health Care EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Amrutanjan Health Care's enterprise value is ₹19,425 Mil. Amrutanjan Health Care's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ₹4,518 Mil. Therefore, Amrutanjan Health Care's EV-to-Revenue for today is 4.30.

The historical rank and industry rank for Amrutanjan Health Care's EV-to-Revenue or its related term are showing as below:

NSE:AMRUTANJAN' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.73   Med: 4.65   Max: 16.55
Current: 4.31

During the past 13 years, the highest EV-to-Revenue of Amrutanjan Health Care was 16.55. The lowest was 2.73. And the median was 4.65.

NSE:AMRUTANJAN's EV-to-Revenue is ranked worse than
70.24% of 971 companies
in the Drug Manufacturers industry
Industry Median: 2.44 vs NSE:AMRUTANJAN: 4.31

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-05), Amrutanjan Health Care's stock price is ₹731.70. Amrutanjan Health Care's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ₹156.37. Therefore, Amrutanjan Health Care's PS Ratio for today is 4.68.


Amrutanjan Health Care EV-to-Revenue Historical Data

The historical data trend for Amrutanjan Health Care's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amrutanjan Health Care EV-to-Revenue Chart

Amrutanjan Health Care Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.47 5.23 3.94 3.75 3.69

Amrutanjan Health Care Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.75 5.05 4.87 4.69 3.69

Competitive Comparison of Amrutanjan Health Care's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Amrutanjan Health Care's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amrutanjan Health Care's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amrutanjan Health Care's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Amrutanjan Health Care's EV-to-Revenue falls into.


;
;

Amrutanjan Health Care EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Amrutanjan Health Care's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=19425.112/4518.163
=4.30

Amrutanjan Health Care's current Enterprise Value is ₹19,425 Mil.
Amrutanjan Health Care's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4,518 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amrutanjan Health Care  (NSE:AMRUTANJAN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Amrutanjan Health Care's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=731.70/156.367
=4.68

Amrutanjan Health Care's share price for today is ₹731.70.
Amrutanjan Health Care's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹156.37.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amrutanjan Health Care EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Amrutanjan Health Care's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Amrutanjan Health Care Business Description

Traded in Other Exchanges
Address
No. 103 (Old No. 42-45), Luz Church Road, Mylapore, Chennai, TN, IND, 600 004
Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products. The company operates through the following segments: OTC Products, Beverages, and Others. The majority of the revenue is generated from its OTC segment which is engaged in the manufacturing products of pain management, congestion management, and hygiene. Its beverage segment includes manufacturing fruit juices and oral rehydration drinks. Some of its products include Roll-on, Spray, Balm, Cough Syrup, Sanitary napkins, and inhalers. Geographically, it generates the majority of the revenue from India.

Amrutanjan Health Care Headlines

No Headlines